Back to Search Start Over

Use of Paliperidone Palmitate Throughout a Schizoaffective Disorder Patient's Gestation Period.

Authors :
Zamora Rodríguez FJ
Benítez Vega C
Sánchez-Waisen Hernández MR
Guisado Macías JA
Vaz Leal FJ
Source :
Pharmacopsychiatry [Pharmacopsychiatry] 2017 Jan; Vol. 50 (1), pp. 38-40. Date of Electronic Publication: 2016 Jul 14.
Publication Year :
2017

Abstract

Introduction: Paliperidone palmitate treatment of schizophrenia or schizoaffective disorder is effective and well tolerated, but there is almost no data on its safety during pregnancy. Case report: An analysis is made of the safety and tolerability of paliperidone palmitate treatment throughout the gestation period in a 34-year-old patient diagnosed with schizoaffective disorder. Discussion: Paliperidone palmitate treatment throughout the gestation period was safe and well tolerated by both mother and foetus, there being no malformations or other perinatal complications in the newborn to date.<br /> (© Georg Thieme Verlag KG Stuttgart · New York.)

Details

Language :
English
ISSN :
1439-0795
Volume :
50
Issue :
1
Database :
MEDLINE
Journal :
Pharmacopsychiatry
Publication Type :
Academic Journal
Accession number :
27414740
Full Text :
https://doi.org/10.1055/s-0042-110492